My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Suramin antiviral therapy in the acquired immunodeficiency syndrome. Clinical, immunological, and virologic results.

    Levine AM, Gill PS, Cohen J, Hawkins JG, Formenti SC, Aguilar S, Meyer PR, Krailo M, Parker J, Rasheed S.

    Ann Intern Med. 1986 Jul;105(1):32-7.PMID: 2424353 [PubMed - indexed for MEDLINE]Related articles

    2.

    Suramin in the treatment of AIDS: mechanism of action.

    De Clercq E.

    Antiviral Res. 1987 Jan;7(1):1-10. Review. Erratum in: Antiviral Res 1987 Mar;7(3):185. PMID: 2432836 [PubMed - indexed for MEDLINE]Related articles

    3.

    Persistence of human immunodeficiency virus antigenemia in patients with the acquired immunodeficiency syndrome treated with a reverse transcriptase inhibitor, suramin. Ten-patient case-control study.

    Eeftinck Schattenkerk JK, Danner SA, Lange JM, Paul DA, van Boxtel CJ, Miedema F, Schellekens PT, Goudsmit J.

    Arch Intern Med. 1988 Jan;148(1):209-11.PMID: 2447847 [PubMed - indexed for MEDLINE]Related articles

    4.

    Implications of the discovery of HTLV-III for the treatment of AIDS.

    Yarchoan R, Mitsuya H, Matsushita S, Broder S.

    Cancer Res. 1985 Sep;45(9 Suppl):4685s-4688s.PMID: 2410113 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Prospects of therapy for infections with human T-lymphotropic virus type III.

    Hirsch MS, Kaplan JC.

    Ann Intern Med. 1985 Nov;103(5):750-5. Review.PMID: 2413793 [PubMed - indexed for MEDLINE]Related articles

    6.

    Suramin therapy in AIDS and related disorders. Report of the US Suramin Working Group.

    Cheson BD, Levine AM, Mildvan D, Kaplan LD, Wolfe P, Rios A, Groopman JE, Gill P, Volberding PA, Poiesz BJ, et al.

    JAMA. 1987 Sep 11;258(10):1347-51.PMID: 3650339 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lack of response to suramin in patients with AIDS and AIDS-related complex.

    Kaplan LD, Wolfe PR, Volberding PA, Feorino P, Levy JA, Abrams DI, Kiprov D, Wong R, Kaufman L, Gottlieb MS.

    Am J Med. 1987 Mar 23;82(3 Spec No):615-20.PMID: 3548350 [PubMed - indexed for MEDLINE]Related articles

    8.

    Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo.

    Broder S, Yarchoan R, Collins JM, Lane HC, Markham PD, Klecker RW, Redfield RR, Mitsuya H, Hoth DF, Gelmann E, et al.

    Lancet. 1985 Sep 21;2(8456):627-30.PMID: 2863631 [PubMed - indexed for MEDLINE]Related articles

    9.

    Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection.

    Collins JM, Klecker RW Jr, Yarchoan R, Lane HC, Fauci AS, Redfield RR, Broder S, Myers CE.

    J Clin Pharmacol. 1986 Jan;26(1):22-6.PMID: 3005375 [PubMed - indexed for MEDLINE]Related articles

    10.

    Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV).

    Balzarini J, Mitsuya H, De Clercq E, Broder S.

    Int J Cancer. 1986 Mar 15;37(3):451-7.PMID: 2419266 [PubMed - indexed for MEDLINE]Related articles

    11.

    Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.

    Mitsuya H, Matsushita S, Yarchoan R, Broder S.

    Princess Takamatsu Symp. 1984;15:277-88. Review.PMID: 6085846 [PubMed - indexed for MEDLINE]Related articles

    12.

    Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.

    Cattelan AM, Calabrò ML, Gasperini P, Aversa SM, Zanchetta M, Meneghetti F, De Rossi A, Chieco-Bianchi L.

    J Natl Cancer Inst Monogr. 2001;(28):44-9.PMID: 11158206 [PubMed - indexed for MEDLINE]Related articles

    13.

    Inhibitors of retroviral DNA polymerase: their implication in the treatment of AIDS.

    Chandra P, Vogel A, Gerber T.

    Cancer Res. 1985 Sep;45(9 Suppl):4677s-4684s. Review.PMID: 2410112 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.

    Shearer GM, Salahuddin SZ, Markham PD, Joseph LJ, Payne SM, Kriebel P, Bernstein DC, Biddison WE, Sarngadharan MG, Gallo RC.

    J Clin Invest. 1985 Oct;76(4):1699-704.PMID: 2997287 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Immunological and virological investigation in patients with lymphoadenopathy syndrome and in a population at risk for acquired immunodeficiency syndrome (AIDS), with particular focus on the detection of antibodies to human T-lymphotropic retroviruses (HTLV III).

    Sirianni MC, Rossi P, Scarpati B, Ragona G, Seminara R, Bonomo G, Aiuti F.

    J Clin Immunol. 1985 Jul;5(4):261-8.PMID: 2995433 [PubMed - indexed for MEDLINE]Related articles

    16.

    Prevalence of AIDS-associated retrovirus and antibodies among male homosexuals at risk for AIDS in Greenwich Village.

    Casareale D, Dewhurst S, Sonnabend J, Sinangil F, Purtilo DT, Volsky DJ.

    AIDS Res. 1984-1985;1(6):407-21.PMID: 6085926 [PubMed - indexed for MEDLINE]Related articles

    17.

    HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.

    Volsky DJ, Wu YT, Sinangil F, Goldsmith JC.

    AIDS Res. 1986 Feb;2(1):51-61.PMID: 2424467 [PubMed - indexed for MEDLINE]Related articles

    18.

    Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.

    Rogers MF, Ewing EP Jr, Warfield D, Hardy AM, Emery DR, Wolf GC.

    Obstet Gynecol. 1986 Sep;68(3 Suppl):2S-6S.PMID: 3016628 [PubMed - indexed for MEDLINE]Related articles

    19.

    Suppression of acute viremia by short-term postexposure prophylaxis of simian/human immunodeficiency virus SHIV-RT-infected monkeys with a novel reverse transcriptase inhibitor (GW420867) allows for development of potent antiviral immune responses resulting in efficient containment of infection.

    Mori K, Yasutomi Y, Sawada S, Villinger F, Sugama K, Rosenwith B, Heeney JL, Uberla K, Yamazaki S, Ansari AA, Rübsamen-Waigmann H.

    J Virol. 2000 Jul;74(13):5747-53.PMID: 10846052 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

    Yarchoan R, Redfield RR, Broder S.

    J Clin Invest. 1986 Aug;78(2):439-47.PMID: 3016028 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity